Literature DB >> 1362617

Operational criteria for senile dementia of Lewy body type (SDLT).

I G McKeith1, R H Perry, A F Fairbairn, S Jabeen, E K Perry.   

Abstract

Recent reports have suggested that brain stem and cortical Lewy body formation may identify a neurodegenerative disorder in elderly demented individuals which accounts for up to 20% of cases of senile dementia coming to autopsy. Retrospective analysis of case notes of 21 autopsy patients with neuropathologically proven senile dementia of Lewy body type (SDLT) and 37 cases with neuropathologically proven Alzheimer's disease (AD) identified a characteristic clinical syndrome in SDLT. Fluctuating cognitive impairment; psychotic features including visual and auditory hallucinations, and paranoid delusions; depressive symptoms; falling and unexplained losses of consciousness were all seen significantly more often than in AD. Over half of the SDLT patients in this series who were given neuroleptics in standard dose showed acute and often irreversible adverse reactions indicative of a neuroleptic sensitivity syndrome. The survival time of drug treated patients was reduced by 50%. Operational criteria to aid in the clinical distinction between SDLT and AD patients are proposed and hypotheses regarding possible aetiology and treatment discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362617     DOI: 10.1017/s0033291700038484

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  48 in total

Review 1.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

2.  Clinical and imaging features of Othello's syndrome.

Authors:  J Graff-Radford; J L Whitwell; Y E Geda; K A Josephs
Journal:  Eur J Neurol       Date:  2011-04-25       Impact factor: 6.089

3.  [Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].

Authors:  M Omerovic; S J Teipel; T Hampel
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

4.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 5.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

Review 6.  Neuropathological and neuroradiological correlates of paranoid symptoms in organic mental disease.

Authors:  A Burns; H Forstl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

7.  Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.

Authors:  Z Walker; D C Costa; A G Janssen; R W Walker; G Livingstone; C L Katona
Journal:  Eur J Nucl Med       Date:  1997-06

8.  Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

Authors:  T A Ala; K H Yang; J H Sung; W H Frey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

9.  12-month incidence, prevalence, persistence, and treatment of mental disorders among individuals recently admitted to assisted living facilities in Maryland.

Authors:  Quincy M Samus; Chiadi U Onyike; Deirdre Johnston; Lawrence Mayer; Matthew McNabney; Alva S Baker; Jason Brandt; Peter V Rabins; Constantine G Lyketsos; Adam Rosenblatt
Journal:  Int Psychogeriatr       Date:  2013-01-07       Impact factor: 3.878

10.  Predictors of providing informed consent or assent for research participation in assisted living residents.

Authors:  Betty S Black; Jason Brandt; Peter V Rabins; Quincy M Samus; Cynthia D Steele; Constantine G Lyketsos; Adam Rosenblatt
Journal:  Am J Geriatr Psychiatry       Date:  2008-01       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.